Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.40 |
| ▸ | NPY1R | P25929 | 4/20 | 0.37 |
| ▸ | NPY4R | P50391 | 2/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA4 | P22748 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.36 |
| ▸ | AKT1 | P31749 | 1/20 | 0.34 |
| ▸ | PLK1 | P53350 | 2/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22140639 | 0.92 | MGLL (0.47) | MGLLCA2CA12CA1CA4 | |
| SCHEMBL22806639 | 0.92 | MGLL (0.47) | MGLLCA2CA12CA1CA4 | |
| SCHEMBL16543617 | 0.92 | MGLL (0.47) | MGLLCA2CA12CA1CA4 | |
| SCHEMBL15750346 | 0.92 | MGLL (0.47) | MGLLCA2CA12CA1CA4 | |
| Trifluoroacetic Acid SCHEMBL20677193 | 0.91 | PTGS1 (0.44) | MGLLNPY1RNPY4RDRD2DRD3 | |
| Trifluoroacetic Acid SCHEMBL20677215 | 0.91 | PTGS1 (0.44) | MGLLNPY1RNPY4RDRD2DRD3 | |
| SCHEMBL19840266 | 0.90 | MGLL (0.45) | MGLLCA2CA12CA1CA4 | |
| Trifluoroacetic Acid SCHEMBL20263649 | 0.88 | PKM (0.41) | MGLLNPY1RNPY4RDRD2DRD3 | |
| SCHEMBL26040916 | 0.88 | MGLL (0.42) | MGLLCA2CA12CA1CA4 | |
| Trifluoroacetic Acid SCHEMBL28645461 | 0.87 | PKM (0.41) | MGLLNPY1RNPY4RDRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260077076-A1 | AGENTS FOR CLEAVING LABELS FROM BIOMOLECULES IN VIVO | TAGWORKS PHARMACEUTICALS B.V. (NL) | 2026-03-19 | — | — | US | disclosed |
| EP-3983020-B9 | AGENTS FOR CLEAVING LABELS FROM BIOMOLECULES IN VIVO | TAGWORKS PHARMACEUTICALS B V (NL) | 2024-10-16 | — | — | EP | disclosed |
| EP-4424713-A2 | AGENTS FOR CLEAVING LABELS FROM BIOMOLECULES IN VIVO | Tagworks Pharmaceuticals B.V. (NL) | 2024-09-04 | — | — | EP | disclosed |
| EP-3983020-B1 | AGENTS FOR CLEAVING LABELS FROM BIOMOLECULES IN VIVO | TAGWORKS PHARMACEUTICALS B V (NL) | 2024-06-26 | — | — | EP | disclosed |
| EP-3983363-B1 | COMPOUNDS FOR FAST AND EFFICIENT CLICK RELEASE | TAGWORKS PHARMACEUTICALS B V (NL) | 2024-04-10 | — | — | EP | disclosed |
| US-20230121556-A1 | COMPOUNDS FOR FAST AND EFFICIENT CLICK RELEASE | TAGWORKS PHARMACEUTICALS B.V. (NL) | 2023-04-20 | — | — | US | disclosed |
| US-20220331458-A1 | AGENTS FOR CLEAVING LABELS FROM BIOMOLECULES IN VIVO | TAGWORKS PHARMACEUTICALS B.V. (NL) | 2022-10-20 | — | — | US | disclosed |
| EP-3983363-A1 | COMPOUNDS FOR FAST AND EFFICIENT CLICK RELEASE | Tagworks Pharmaceuticals B.V. (NL) | 2022-04-20 | — | — | EP | disclosed |
| EP-3983020-A1 | AGENTS FOR CLEAVING LABELS FROM BIOMOLECULES IN VIVO | Tagworks Pharmaceuticals B.V. (NL) | 2022-04-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260077076-A1 | AGENTS FOR CLEAVING LABELS FROM BIOMOLECULES IN VIVO | FCGR3B, MSR1, FCGR2A | MGLL 2175/4885NPY1R 113/4885NPY4R 820/4885 |
| US-20230121556-A1 | COMPOUNDS FOR FAST AND EFFICIENT CLICK RELEASE | LTB4R, LTC4S, LTA4H | MGLL 941/4885NPY1R 539/4885NPY4R 392/4885 |
| US-20220331458-A1 | AGENTS FOR CLEAVING LABELS FROM BIOMOLECULES IN VIVO | DNASE1L3, CTSE, DCLRE1B | MGLL 1376/4885NPY1R 3651/4885NPY4R 4209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.